Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (4) , 1084-1091
- https://doi.org/10.1016/s0003-4975(00)01093-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cardiopulmonary bypass and the inflammatory response: A role for serine protease inhibitors?Journal of Cardiothoracic and Vascular Anesthesia, 1997
- Biocompatibility of heparin-coated extracorporeal bypass circuits: A randomized, masked clinical trialThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass graftingThe Annals of Thoracic Surgery, 1996
- Preventing the inflammatory response to open-heart surgery: The role of aprotinin and other protease inhibitorsInternational Journal of Cardiology, 1996
- Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass–induced inflammation in humansThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994
- Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1992